Melbourne Health
Clinical trials sponsored by Melbourne Health, explained in plain language.
-
Experimental drug AB-218 tested in brain tumor patients
Disease control CompletedThis study tested a drug called AB-218 (safusidenib) in 14 adults with a specific type of slow-growing brain tumor (IDH1 mutated low grade glioma) who were already scheduled for surgery. The goal was to see if it's possible to measure how much drug gets into the tumor and to chec…
Phase: EARLY_PHASE1 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a drug duo save insulin-making cells in type 1 diabetes?
Disease control CompletedThis study tested whether combining two safe immune therapies—abatacept injections and nasal insulin—can help preserve the pancreas's ability to make insulin in people recently diagnosed with type 1 diabetes. The goal is to make blood sugar control easier and reduce the need for …
Phase: PHASE2 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC